{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:55:03Z","timestamp":1775307303844,"version":"3.50.1"},"reference-count":27,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1210\/en.2018-00283","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T14:21:20Z","timestamp":1527603680000},"page":"2884-2890","source":"Crossref","is-referenced-by-count":15,"title":["AR Signaling in Prostate Cancer Regulates a Feed-Forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation"],"prefix":"10.1210","volume":"159","author":[{"given":"Daniel","family":"Hettel","sequence":"first","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio"},{"name":"Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"},{"name":"Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio"},{"name":"Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"},{"name":"Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alyamani","sequence":"additional","affiliation":[{"name":"Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[{"name":"Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio"},{"name":"Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"},{"name":"Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio"},{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"issue":"9","key":"2019041122025299100_B1","doi-asserted-by":"crossref","first-page":"a030452","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"2019041122025299100_B2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"issue":"33","key":"2019041122025299100_B3","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"Chang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019041122025299100_B4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","article-title":"A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer","volume":"154","author":"Chang","year":"2013","journal-title":"Cell"},{"issue":"10","key":"2019041122025299100_B5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1470-2045(16)30227-3","article-title":"HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study","volume":"17","author":"Hearn","year":"2016","journal-title":"Lancet Oncol"},{"issue":"4","key":"2019041122025299100_B6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamaoncol.2017.3164","article-title":"Association of HSD3B1 genotype with response to androgen-deprivation therapy for biochemical recurrence after radiotherapy for localized prostate cancer","volume":"4","author":"Hearn","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"2019041122025299100_B7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2017.0147","article-title":"Independent validation of effect of HSD3B1 genotype on response to androgen-deprivation therapy in prostate cancer","volume":"3","author":"Agarwal","year":"2017","journal-title":"JAMA Oncol"},{"key":"2019041122025299100_B8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2018.36.6_suppl.179","article-title":"Independent validation of missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer","volume":"36","author":"Shiota","year":"2018","journal-title":"J Clin Oncol."},{"issue":"3","key":"2019041122025299100_B9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrurol.2017.201","article-title":"HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer","volume":"15","author":"Hettel","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2019041122025299100_B10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9440(10)63112-4","article-title":"Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance","volume":"164","author":"Holzbeierlein","year":"2004","journal-title":"Am J Pathol"},{"issue":"1","key":"2019041122025299100_B11","first-page":"1449","article-title":"Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer","volume":"18","author":"Hamid","year":"2013","journal-title":"Mol Med"},{"issue":"1-2","key":"2019041122025299100_B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2008.11.021","article-title":"HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer","volume":"301","author":"Rasiah","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"23","key":"2019041122025299100_B13","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-12-1335","article-title":"Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors","volume":"72","author":"Mitsiades","year":"2012","journal-title":"Cancer Res"},{"issue":"7-8","key":"2019041122025299100_B14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2119\/molmed.2010.00143","article-title":"Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Mol Med"},{"issue":"11","key":"2019041122025299100_B15","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res"},{"issue":"4","key":"2019041122025299100_B16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/en.2016-1926","article-title":"Inverse regulation of DHT synthesis enzymes 5\u03b1-reductase types 1 and 2 by the androgen receptor in prostate cancer","volume":"158","author":"Audet-Walsh","year":"2017","journal-title":"Endocrinology"},{"issue":"11","key":"2019041122025299100_B17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1078-0432.CCR-14-2352","article-title":"ERG\/AKR1C3\/AR constitutes a feed-forward loop for AR signaling in prostate cancer cells","volume":"21","author":"Powell","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2019041122025299100_B18","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1210\/endo.140.10.7038","article-title":"Induction of 3\u03b2-hydroxysteroid dehydrogenase\/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines","volume":"140","author":"Gingras","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"2019041122025299100_B19","first-page":"66","article-title":"Induction of 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13","volume":"13","author":"Gingras","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041122025299100_B20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.steroids.2017.08.011","article-title":"Development of monoclonal antibodies against the human 3\u03b2-hydroxysteroid dehydrogenase\/isomerase isozymes","volume":"127","author":"Gomez-Sanchez","year":"2017","journal-title":"Steroids"},{"key":"2019041122025299100_B21","doi-asserted-by":"crossref","first-page":"D658","DOI":"10.1093\/nar\/gkw983","article-title":"Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse","volume":"45","author":"Mei","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2019041122025299100_B22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"7504","key":"2019041122025299100_B23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature13229","article-title":"Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer","volume":"510","author":"Asangani","year":"2014","journal-title":"Nature"},{"issue":"33","key":"2019041122025299100_B24","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1038\/onc.2015.496","article-title":"FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression","volume":"35","author":"Zhao","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"2019041122025299100_B25","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1210\/me.2004-0028","article-title":"Transcription enhancer factor-5 and a GATA-like protein determine placental-specific expression of the Type I human 3\u03b2-hydroxysteroid dehydrogenase gene, HSD3B1.","volume":"18","author":"Peng","year":"2004","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2019041122025299100_B26","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/s41598-017-04133-6","article-title":"Proximal GATA-binding sites are essential for human HSD3B1 gene transcription in the placenta","volume":"7","author":"Lai","year":"2017","journal-title":"Sci Rep"},{"issue":"15","key":"2019041122025299100_B27","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1200\/JCO.2017.35.15_suppl.5002","article-title":"A randomized phase II cross-over study of abiraterone + prednisone (ABI) vs enzalutamide (ENZ) for patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC)","volume":"35","author":"Chi","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/8\/2884\/25144501\/en.2018-00283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T09:36:15Z","timestamp":1555061775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/8\/2884\/5005852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,5,29]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2018-00283","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,5,29]]}}}